[HTML][HTML] A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
…, R Roberts, P van Nguyen, J Kassis… - … England Journal of …, 1999 - Mass Medical Soc
Background Patients who have a first episode of venous thromboembolism in the absence
of known risk factors for thrombosis (idiopathic thrombosis) are often treated with …
of known risk factors for thrombosis (idiopathic thrombosis) are often treated with …
[HTML][HTML] Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism
…, C Demers, SR Kahn, J Kassis… - … England Journal of …, 2003 - Mass Medical Soc
Background Warfarin is very effective in preventing recurrent venous thromboembolism but
is also associated with a substantial risk of bleeding. After three months of conventional …
is also associated with a substantial risk of bleeding. After three months of conventional …
Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis
…, A Roussin, S Desmarais, F Joyal, J Kassis… - Annals of internal …, 2008 - acpjournals.org
Background: The reason some patients with deep venous thrombosis (DVT) develop the
postthrombotic syndrome is not well understood. Objective: To determine the frequency, time …
postthrombotic syndrome is not well understood. Objective: To determine the frequency, time …
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
…, MJ Miron, E Yeo, R Smith, S Schulman, J Kassis… - The Lancet, 2014 - thelancet.com
Background Post-thrombotic syndrome (PTS) is a common and burdensome complication
of deep venous thrombosis (DVT). Previous trials suggesting benefit of elastic compression …
of deep venous thrombosis (DVT). Previous trials suggesting benefit of elastic compression …
Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant
…, AYY Lee, E Yeo, S Solymoss, J Kassis… - JAMA internal …, 2019 - jamanetwork.com
Importance Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC)
and request elective surgery or procedure present a common clinical situation yet …
and request elective surgery or procedure present a common clinical situation yet …
Prospective evaluation of health-related quality of life in patients with deep venous thrombosis
…, S Desmarais, F Joyal, J Kassis… - Archives of Internal …, 2005 - jamanetwork.com
Background To our knowledge, the burden of deep venous thrombosis from the patient’s
perspective has not been quantified. We evaluated health-related quality of life (QOL) after …
perspective has not been quantified. We evaluated health-related quality of life (QOL) after …
VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis
…, A Roussin, S Desmarais, F Joyal, J Kassis… - Journal of clinical …, 2006 - Elsevier
OBJECTIVE: To assess the validity of VEINES-QOL/Sym, a patient-reported questionnaire
to evaluate quality of life and symptoms in patients with deep venous thrombosis (DVT). …
to evaluate quality of life and symptoms in patients with deep venous thrombosis (DVT). …
Prevention of venous thromboembolism after knee arthroplasty: a randomized, double-blind trial comparing enoxaparin with warfarin
…, B l'Esperance, C Demers, J Kassis… - Annals of internal …, 1996 - acpjournals.org
Objective: To compare the effectiveness and safety of fixed-dose enoxaparin and adjusted-dose
warfarin in preventing venous thromboembolism after knee arthroplasty. Design: A …
warfarin in preventing venous thromboembolism after knee arthroplasty. Design: A …
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial
…, C Demers, SR Kahn, J Kassis… - Blood, The Journal …, 2008 - ashpublications.org
We sought to determine whether thrombophilic defects increase recurrent venous thromboembolism
(VTE) during warfarin therapy. Six hundred sixty-one patients with unprovoked VTE …
(VTE) during warfarin therapy. Six hundred sixty-one patients with unprovoked VTE …
Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia
…, J Brandwein, S Kambhampati, J Kassis… - British journal of …, 2009 - Wiley Online Library
MGCD0103, an orally available class I histone deacetylase (HDAC) inhibitor, was examined
for pre‐clinical activity in chronic lymphocytic leukaemia (CLL). A phase II clinical trial was …
for pre‐clinical activity in chronic lymphocytic leukaemia (CLL). A phase II clinical trial was …